| Drug Name: | Aclarubicin (57576-44-0) |
|---|---|
| PubChem ID: | 123134262 |
| SMILES: | CC[C@]1(C[C@@H](C2=C([C@H]1C(=O)OC)C=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)OC5CC([C@@H]([C@@H](O5)C)O[C@@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O |
| InchiKey: | USZYSDMBJDPRIF-MCLSBFAVSA-N |
| Therapeutic Category: | Antibiotics, Antineoplastic Agents, Enzyme Inhibitors, Topoisomerase II Inhibitors, Topoisomerase Inhibitors |
| Molecular Weight (dalton) | : | 811.878 |
| LogP | : | 3.1577 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 16 |
| Hydrogen Bond Donor Count | : | 4 |
| Total Polar Surface Area | : | 217.05 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Leukemia Myeloid Acute | MetaADEDB |
| Necrosis | MetaADEDB |
| Torsades De Pointes | MetaADEDB |